BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 30592962)

  • 1. Micromolar concentrations of citalopram or escitalopram inhibit glycoprotein VI-mediated and integrin αIIbβ3-mediated signaling in human platelets.
    Tseng YL; Braun A; Chang JP; Chiang ML; Tseng CY; Chen W
    Toxicol Appl Pharmacol; 2019 Feb; 364():106-113. PubMed ID: 30592962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct contributions of glycoprotein VI and alpha(2)beta(1) integrin to the induction of platelet protein tyrosine phosphorylation and aggregation.
    Kamiguti AS; Theakston RD; Watson SP; Bon C; Laing GD; Zuzel M
    Arch Biochem Biophys; 2000 Feb; 374(2):356-62. PubMed ID: 10666318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of the effects of Syk and BTK inhibitors on GPVI-mediated platelet signaling and function.
    Zheng TJ; Lofurno ER; Melrose AR; Lakshmanan HHS; Pang J; Phillips KG; Fallon ME; Kohs TCL; Ngo ATP; Shatzel JJ; Hinds MT; McCarty OJT; Aslan JE
    Am J Physiol Cell Physiol; 2021 May; 320(5):C902-C915. PubMed ID: 33689480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A selective serotonin reuptake inhibitor, citalopram, inhibits collagen-induced platelet aggregation and activation.
    Tseng YL; Chiang ML; Huang TF; Su KP; Lane HY; Lai YC
    Thromb Res; 2010 Dec; 126(6):517-23. PubMed ID: 20961601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet activation and signal transduction by convulxin, a C-type lectin from Crotalus durissus terrificus (tropical rattlesnake) venom via the p62/GPVI collagen receptor.
    Polgár J; Clemetson JM; Kehrel BE; Wiedemann M; Magnenat EM; Wells TN; Clemetson KJ
    J Biol Chem; 1997 May; 272(21):13576-83. PubMed ID: 9153205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A critical role for the regulation of Syk from agglutination to aggregation in human platelets.
    Shih CH; Chiang TB; Wang WJ
    Biochem Biophys Res Commun; 2014 Jan; 443(2):580-5. PubMed ID: 24326074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ligand binding rapidly induces disulfide-dependent dimerization of glycoprotein VI on the platelet plasma membrane.
    Arthur JF; Shen Y; Kahn ML; Berndt MC; Andrews RK; Gardiner EE
    J Biol Chem; 2007 Oct; 282(42):30434-41. PubMed ID: 17690106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective serotonin reuptake inhibitors reduce P2Y12 receptor-mediated amplification of platelet aggregation.
    Tseng YL; Chiang ML; Lane HY; Su KP; Lai YC
    Thromb Res; 2013 Apr; 131(4):325-32. PubMed ID: 23490430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiplatelet activity of chrysin via inhibiting platelet αIIbβ3-mediated signaling pathway.
    Liu G; Xie W; He AD; Da XW; Liang ML; Yao GQ; Xiang JZ; Gao CJ; Ming ZY
    Mol Nutr Food Res; 2016 Sep; 60(9):1984-93. PubMed ID: 27006308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PPARγ agonists negatively regulate αIIbβ3 integrin outside-in signaling and platelet function through up-regulation of protein kinase A activity.
    Unsworth AJ; Kriek N; Bye AP; Naran K; Sage T; Flora GD; Gibbins JM
    J Thromb Haemost; 2017 Feb; 15(2):356-369. PubMed ID: 27896950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. cAMP- and cGMP-elevating agents inhibit GPIbα-mediated aggregation but not GPIbα-stimulated Syk activation in human platelets.
    Makhoul S; Trabold K; Gambaryan S; Tenzer S; Pillitteri D; Walter U; Jurk K
    Cell Commun Signal; 2019 Sep; 17(1):122. PubMed ID: 31519182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Murine GPVI stimulates weak integrin activation in PLCgamma2-/- platelets: involvement of PLCgamma1 and PI3-kinase.
    Suzuki-Inoue K; Inoue O; Frampton J; Watson SP
    Blood; 2003 Aug; 102(4):1367-73. PubMed ID: 12730118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of Src but not Syk causes weak reversal of GPVI-mediated platelet aggregation measured by light transmission aggregometry.
    Cheung HYF; Moran LA; Sickmann A; Heemskerk JWM; Garcia Á; Watson SP
    Platelets; 2022 Nov; 33(8):1293-1300. PubMed ID: 35535424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycoprotein VI-mediated platelet fibrinogen receptor activation occurs through calcium-sensitive and PKC-sensitive pathways without a requirement for secreted ADP.
    Quinton TM; Ozdener F; Dangelmaier C; Daniel JL; Kunapuli SP
    Blood; 2002 May; 99(9):3228-34. PubMed ID: 11964287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The novel Syk inhibitor R406 reveals mechanistic differences in the initiation of GPVI and CLEC-2 signaling in platelets.
    Spalton JC; Mori J; Pollitt AY; Hughes CE; Eble JA; Watson SP
    J Thromb Haemost; 2009 Jul; 7(7):1192-9. PubMed ID: 19422460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peptide LSARLAF induces integrin β3 dependent outside-in signaling in platelets.
    Niu H; Xu Z; Li D; Zhang L; Wang K; Taylor DB; Liu J; Gartner TK
    Thromb Res; 2012 Aug; 130(2):203-9. PubMed ID: 22482832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of proline-rich tyrosine kinase 2 in platelet activation: tyrosine phosphorylation mostly dependent on alphaIIbbeta3 integrin and protein kinase C, translocation to the cytoskeleton and association with Shc through Grb2.
    Ohmori T; Yatomi Y; Asazuma N; Satoh K; Ozaki Y
    Biochem J; 2000 Apr; 347(Pt 2):561-9. PubMed ID: 10749687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ITAM receptor-mediated generation of reactive oxygen species in human platelets occurs via Syk-dependent and Syk-independent pathways.
    Arthur JF; Qiao J; Shen Y; Davis AK; Dunne E; Berndt MC; Gardiner EE; Andrews RK
    J Thromb Haemost; 2012 Jun; 10(6):1133-41. PubMed ID: 22489915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic and pharmacological analyses of Syk function in alphaIIbbeta3 signaling in platelets.
    Law DA; Nannizzi-Alaimo L; Ministri K; Hughes PE; Forsyth J; Turner M; Shattil SJ; Ginsberg MH; Tybulewicz VL; Phillips DR
    Blood; 1999 Apr; 93(8):2645-52. PubMed ID: 10194444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiplatelet action of indirubin-3'-monoxime through suppression of glycoprotein VI-mediated signal transduction: a possible role for ERK signaling in platelets.
    Lee JJ; Han JH; Jung SH; Lee SG; Kim IS; Cuong NM; Huong TT; Khanh PN; Kim YH; Yun YP; Ma JY; Myung CS
    Vascul Pharmacol; 2014 Dec; 63(3):182-92. PubMed ID: 25451564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.